Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Synagis Prescribers (US)

Articles with lock require a subscription to GLG News | Request a free trial
December 17, 2007
Cut in reimbursement vs. upfront costs....
Analysis of: Leavitt: Doctors Need Electronic Records | www.sfgate.com
Author: GLG Expert Contributor
Hmmmmm. I might as well retire given this choice. Sounds like a lose-lose situation to me
December 17, 2007
A novel approach to an old disease
Analysis of: Cytos Biotechnology announces start of two phase II studies | www.pipelinereview.com
Author: GLG Expert Contributor
The use of an immunodrug to provide more reliable and long-lasting relief to those among us who suffer from house dust mite and cat allergy--what an improvement this would be.    
December 7, 2007
Approval in India means little in U.S.
Analysis of: BHARAT BIOTECH LAUNCHES TWO NEW VACCINES IN INDIA (Bio-Hib and Comvac4-HB vaccines) | www.therapeuticsdaily.com
Author: GLG Expert Contributor
-Bharat has gotten approval in India to sell 2 vaccinations that are used for children -Approval in India means only that the drugs can be sold and used in India -Although the Indian market is large, there may be many competing approved products already available in India and this has little implication...
December 6, 2007
Not a major concern in enuressi treatment
Analysis of: Desmopressin Acetate (marketed as DDAVP Nasal Spray, DDAVP Rhinal Tube, DDAVP, DDVP, Minirin, and Stimate Nasal Spray) | www.fda.gov
Author: GLG Expert Contributor
With the availability of desmopressin tablets, the treatment of primary nocturnal enuresis in pediatrics has moved away from the intranasal route, which is the highest risk means of delivering the drug.
December 6, 2007
Intriguing, but not really relevant
Analysis of: Antibiotics and Topical Nasal Steroid for Treatment of Acute Maxillary Sinusitis | jama.ama-assn.org
Author: GLG Expert Contributor
The study compared amoxicillin as the antibiotic used in the treatment group with controls with no antibiotic and with nasal steroids. Amoxicillin is not the antibiotic of choice for sinusitis, however.
December 4, 2007
The Law of Unintended Consequences strikes again
Analysis of: Strategies to Avoid Medicare’s Big Hole | www.nytimes.com
Author: GLG Expert Contributor
The pharmaceutical companies were able to prevail on preveenting Medicare from negotiating for lower prices. Seems that the huge increase in generic utilization is a result they did not forsee.
December 4, 2007
Another weapon in the armamentariun for treating this difficult condition
Analysis of: Forest Laboratories and Lundbeck announces positive results of Lexapro(R) phase III study in adolescents with major depression | www.pipelinereview.com
Author: GLG Expert Contributor
Adolescent depression is often seen by both psychiatrists and primary care physicians. However, the drugs approved for treatment are limited.
December 3, 2007
In-office diagnosis is nice, but....
Analysis of: Meridian Bioscience Receives FDA Clearance For Two New Rapid Tests For The Detection Of Influenza And Respiratory Syncytial Virus | www.medicalnewstoday.com
Author: GLG Expert Contributor
It is nice to know the causative organism in a sick child, but the utility of this test is limited by the lack of specific therapies once the diagnosis is made.
November 28, 2007
Preventive care is a big part of the answer
Analysis of: CBO: Medicare and Medicaid spending growth unsustainable | www.ama-assn.org
Author: GLG Expert Contributor
Unfortunately, few if any health plans put any value on preventive care. As pediatricians, we struggle daily with the huge costs of vaccines--the number one preventive public health measure of the last hundred years--while reimbursement is not even adequate to cover our costs.   &nbs...
November 28, 2007
Impact may not be great
Analysis of: Akorn, Inc. Announces FDA Approval For Unit Dose Preservative Free Tetanus Diphtheria Vaccine | www.medicalnewstoday.com
Author: GLG Expert Contributor
Preservative-free vaccines are always welcome, but the market for a tetanus-diphtheria vaccine alone is limited by newer recommendations that adolescents and adults also be immunized against pertussis.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next91 to 100 of 156

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203